Coronavirus Patients in Limbo as Gilead Suspends Emergency Drug Access
The company says it will switch to a broader approach for its experimental drug, remdesivir. But it was overwhelmed by demand for a potential treatment promoted by President Trump.
Source: NYT - Category: American Health Authors: Katie Thomas Tags: Drugs (Pharmaceuticals) Coronavirus (2019-nCoV) Clinical Trials Gilead Sciences Inc Quest Diagnostics Inc your-feed-healthcare Trump, Donald J United States Politics and Government Jack Allard Source Type: news
More News: American Health | Clinical Trials | Coronavirus | COVID-19 | Emergency Medicine | Government | Politics | Trump | USA Health